- Home
- OLP vs AUTL Comparison
OLP vs AUTL Comparison
Compare OLP & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | AUTL |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 508.4M | 431.2M |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | OLP | AUTL |
|---|---|---|
| Price | $22.78 | $1.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $27.50 | $8.50 |
| AVG Volume (30 Days) | 66.2K | ★ 1.4M |
| Earning Date | 03-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.08% | N/A |
| EPS Growth | N/A | ★ 28.33 |
| EPS | ★ 1.15 | N/A |
| Revenue | ★ $82,740,000.00 | $10,120,000.00 |
| Revenue This Year | $7.87 | $669.62 |
| Revenue Next Year | $4.40 | $79.78 |
| P/E Ratio | $19.36 | ★ N/A |
| Revenue Growth | 1.02 | ★ 496.00 |
| 52 Week Low | $19.62 | $1.11 |
| 52 Week High | $26.86 | $2.70 |
Technical Indicators
Market Signals| Indicator | OLP | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 41.48 |
| Support Level | $21.94 | $1.27 |
| Resistance Level | $23.63 | $1.52 |
| Average True Range (ATR) | 0.62 | 0.08 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 28.34 | 12.86 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.